期刊文献+

尖锐湿疣患者外周血单一核细胞中干扰素调节因子7和Toll样受体9mRNA的表达 被引量:2

Expressions of interferon regulatory factor 7 and Toll-like receptor 9 in peripheral blood mononuclear cells (PBMCs) of patients with condyioma acuminatum
原文传递
导出
摘要 目的探讨干扰素调节因子7、Toll样受体9在尖锐湿疣发病中的作用及临床意义。方法采用逆转录聚合酶链反应检测25例尖锐湿疣患者外周血单一核细胞中干扰素调节因子7、Toll样受体9mRNA的水平,20例正常人作对照。结果尖锐湿疣患者外周血单一核细胞中干扰素调节因子7与Toll样受体9mRNA表达水平均明显高于正常对照组,差异有统计学意义(P值均〈0.01)。结论尖锐湿疣患者外周血中干扰素调节因子7、Toll样受体9表达升高。 Objective To investigate the role and clinical significance of interferon regulatory factor 7 (IRF7) and Toll-like receptor 9 (TLR9) in the development of eondyloma aeuminatum (CA). Methods Reverse transcription-PCR was performed to analyze the mRNA expressions of IRF7 and TLR9 in peripheral blood mononuclear cells (PBMCs) of 25 patients with CA and 20 normal human controls. Results The expression levels of IRF7 and TLR9 mRNA in PBMCs were significantly higher in the patients with CA than in the controls (both P 〈 0.01 ). Conclusion There is a significant increase in the expression of IRF7 and TLR9 in the PBMCs of patients with CA.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第11期807-808,共2页 Chinese Journal of Dermatology
  • 相关文献

参考文献10

  • 1Del Prete G. The concept of type-1 and type-2 helper T cells and their c~tokines in humans. [nt Rev Immuno[, 1998, 16 (3-4/: 427-455.
  • 2Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell, 2006, 124(4): 783-801.
  • 3Verthelyi C, Klinman DM. lmmunoregulatory activity of CpG oligo nucleotides in humans and nonhuman primates. Clin lmmunol, 2003, 109( 1 ): 64-71.
  • 4马小兵,王海涛,畅继武.干扰素调节因子与Th细胞分化[J].现代免疫学,2006,26(1):76-80. 被引量:4
  • 5Servant M J, Tenoever B, Lin R. Overlapping and distinct mecha- nisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res, 2002, 22( 1 ): 49-58.
  • 6陈燚琼,陈建忠.IRF_7在干扰素诱导中作用的研究进展[J].国际流行病学传染病学杂志,2006,33(6):389-391. 被引量:1
  • 7French AR, Yokoyama WM. Natural killer cells and viral infec- tions. Curr ()pin Immunol, 2003, 15( 1 ): 45-51.
  • 8Yokoyama wM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol, 2004, 22: 405-429.
  • 9Arany I, Goel A, Tyring SK. Interferon response depends on viral transcription in HPV containing lesions. Anticancer Res, 1995, 15 (6B): 2865-2869.
  • 10赵艳阳,李其林,尚智伟,付金玲,李晓辉.尖锐湿疣复发患者外周血单核细胞Toll样受体3、4、9的表达及意义[J].岭南皮肤性病科杂志,2009,16(1):22-25. 被引量:11

二级参考文献39

  • 1付继成,李漫莉,黄玉玲,蒋正义.复发性尖锐湿疣患者PBMC中IFN-γ和IL-4的表达[J].中国麻风皮肤病杂志,2004,20(4):353-354. 被引量:1
  • 2Lohoff M, Mak TW. Roles of interferon-regulatory factors in T-helper-cell differentiation[J]. Nat Rev Immunol, 2005,5(2):125-135.
  • 3Liu J, Cao S, Herman LM, et al. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-4gamma-primed IL-12 production by IFN regulatory factor 1[J]. J Exp Med, 2003,198(8):1265-1276.
  • 4Elser B, Lohoff M, Kock S, et al. 1FN-gamma represses IL-4 expression via IRF1 and IRF2[J]. Immunity,2002,17(6):703-712.
  • 5Niedbala W, Wei XQ, Campbell C, et al. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP[J].Proe Natl Acad Sci USA, 2002,99(25):16186-16191.
  • 6Remoli ME, Giaeomini E, Lutfalla G, et al. Selective expression of type Ⅰ IFN genes in human dendritic cells infected with Mycobacterium tuberculosis[J]. J Immunol, 2002,169(1) :366-374.
  • 7Tominaga N, Ohkusu-Tsukada K, Udono H, et al. Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4 [J]. Int Immunol, 2003, 15(1): 1-10.
  • 8Hu CM, Jang SY, Fanzo JC, et al. Modulation of T cell cytoklne production by interferon regulatory factor-4 [J]. J Biol Chem, 2002,277(51) :49238-49246.
  • 9Lohoff M, Mittrucker HW, Brustle A, et al. Enhanced TCR induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells[J]. J Exp Med, 2004,200(2):247-253.
  • 10Rengarajan Hi, Mowen KA, McBride KD, et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression[J]. J Exp Med,2002,195(8):1003-1012.

共引文献13

同被引文献72

  • 1KawaiT,Akira S.TLR signaling[J].Cell Death Differ,2006,13(5):816-825.
  • 2MatsumotoM,Funami K,Tanabe M,et al.Subcellular localization of Toll-like receptor 3 in human dendritic cells[J].J Immunol,2003,171(9):3154-3162.
  • 3AkiraS,Takeda K.Toll-like receptor signaling[J].Nat Rev Im-munol 2004,4(7):499-511.
  • 4AlegreML,Goldstein DR,Chong AS.Toll-like receptor signaling in transplantation[J].Current Opinion in Organ Transplantation,2008,13(4):358-365.
  • 5George Rozis,Adel Benlahrech,Sai Duraisingham,et al.Human Langerhans ' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands[J].Immunology,2008,124(3):329-338.
  • 6ItohH5Tatematsu M,Watanabe A,et al.UNC93B1 physically as-sociates with human TLR8 and regulates TLR8-mediated signaling[J].PLoS One,2011,6(12):e28500.
  • 7KawaiT,Akira S.The roles of TLRs,RLRs and NLRs in pathogen recognition[J].International Immunology,2009,21(4):317-337.
  • 8Takeuchi0,Akira S,Innate immunity to virus infection,Immuno-logical Reviews[J].2009,227(1):75-86.
  • 9VerstakB,Hertzog P5Mansell A.Toll-like receptor signalling and the clinical benefits that He within[J].Inflamm Res,2007,56(1):1-10.
  • 10Homa-UszynskiSiStenger S,Takeuchi O,et al.Induction of di-rect antimicrobial activity through mammalian Toll-like receptors[J].Science 2001,291(5508):1544-1547.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部